Dr. Babinchak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
190 Pembrooke Cir
Suite 101
Phoenixville, PA 19460Phone+1 610-415-9486Fax+1 610-415-9486- Is this information wrong?
Education & Training
- Ohio State University HospitalFellowship, Infectious Disease, 1987 - 1989
- Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 1984 - 1987
- Northeast Ohio Medical UniversityClass of 1984
Certifications & Licensure
- OH State Medical License 1988 - 2025
- PA State Medical License 1985 - 2024
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects Start of enrollment: 2016 May 27
Publications & Presentations
PubMed
- 127 citationsTigecycline: an update.Gary E. Stein, Timothy Babinchak> ;Diagnostic Microbiology and Infectious Disease. 2013 Apr 1
- 1 citationsClarification to the Systematic Review and Meta-Analysis Involving TigecyclinePaul C. McGovern, Timothy Babinchak, Alvaro Quintana> ;Antimicrobial Agents and Chemotherapy. 2011 Oct 1
- Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.Hawser, S. P., Bouchillon, S. K., Hoban, D. J., Dowzicky, M., Babinchak, T.> ;Int J Antimicrob Agents. 2011 Mar
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: